Caming, Xyle Drix .
HRN: 28-99-14 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
CEFTRIAXONE 1G (VIAL)
05/11/2026
05/17/2026
IVT
500mg
Q12H
T/C CNSI
Checking Initial Appropriateness
05/13/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/13/2026
05/20/2026
IV
95mg
Q8H
CNSI
Checking Initial Appropriateness
05/18/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
05/18/2026
05/25/2026
PO
4ml
Q8
T/c Begining CNS Abscess
Checking Initial Appropriateness
05/18/2026
MUPIROCIN 2%, 15G (TUBE)
05/18/2026
12/14/1901
TOPICAL
15g
BID
T/c Cnsi
Checking Initial Appropriateness
05/19/2026
MUPIROCIN 2%, 15G (TUBE)
05/19/2026
05/26/2026
TOPICAL
As Needed
BID
CNSI
Checking Initial Appropriateness